The DOI matches its Crossref record; 50 of the 50 references it cites were found in a registry or an index.
Continuous Glucose Monitoring: A Review of Successes, Challenges, and Opportunities
Open accessAbstract
Continuous glucose monitoring (CGM) provides information unattainable by intermittent capillary blood glucose, including instantaneous real-time display of glucose level and rate of change of glucose, alerts and alarms for actual or impending hypo- and hyperglycemia, "24/7" coverage, and the ability to characterize glycemic variability. Progressively more accurate and precise, reasonably unobtrusive, small, comfortable, user-friendly devices connect to the Internet to share information and are sine qua non for a closed-loop artificial pancreas. CGM can inform, educate, motivate, and alert people with diabetes. CGM is medically indicated for patients with frequent, severe, or nocturnal hypoglycemia, especially in the presence of hypoglycemia unawareness. Surprisingly, despite tremendous advances, utilization of CGM has remained fairly limited to date. Barriers to use have included the following: (1) lack of Food and Drug Administration approval, to date, for insulin dosing ("nonadjuvant use") in the United States and for use in hospital and intensive care unit settings; (2) cost and variable reimbursement; (3) need for recalibrations; (4) periodic replacement of sensors; (5) day-to-day variability in glycemic patterns, which can limit the predictability of findings based on retrospective, masked "professional" use; (6) time, implicit costs, and inconvenience for uploading of data for retrospective analysis; (7) lack of fair and reasonable reimbursement for physician time; (8) inexperience and lack of training of physicians and other healthcare professionals regarding interpretation of CGM results; (9) lack of standardization of software methods for analysis of CGM data; and (10) need for professional medical organizations to develop and disseminate additional clinical practice guidelines regarding the role of CGM. Ongoing advances in technology and clinical research have addressed several of these barriers. Use of CGM in conjunction with an insulin pump with automated suspension of insulin infusion in response to actual observed or predicted hypoglycemia, as well as progressive refinement of closed-loop systems, is expected to dramatically enhance the clinical utility and utilization of CGM.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Miller, K. M., Foster, N. C., Beck, R. W., Bergenstal, R. M., DuBose, S. N., DiMeglio, L. A., Maahs, D. M., & Tamborlane, W. V. (2015) · Diabetes Care · doi:10.2337/dc15-0078 · Cited by 1,254
The Performance and Usability of a Factory-Calibrated Flash Glucose Monitoring System
Bailey, T., Bode, B. W., Christiansen, M. P., Klaff, L. J., & Alva, S. (2015) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2014.0378 · Cited by 685
Outpatient Glycemic Control with a Bionic Pancreas in Type 1 Diabetes
Russell, S. J., El-Khatib, F. H., Sinha, M., Magyar, K. L., McKeon, K., Goergen, L. G., Balliro, C., Hillard, M. A., Nathan, D. M., & Damiano, E. R. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1314474 · Cited by 602
Home Use of an Artificial Beta Cell in Type 1 Diabetes
Thabit, H., Tauschmann, M., Allen, J. M., Leelarathna, L., Hartnell, S., Wilinska, M. E., Acerini, C. L., Dellweg, S., Benesch, C., Heinemann, L., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1509351 · Cited by 450
The effect of continuous glucose monitoring in well-controlled type 1 diabetes
Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Study Group (2009) · Diabetes Care · doi:10.2337/dc09-0108 · Cited by 399
Real-time continuous glucose monitoring among participants in the T1D Exchange clinic registry
Wong, J. C., Foster, N. C., Maahs, D. M., Raghinaru, D., Bergenstal, R. M., Ahmann, A. J., Peters, A. L., Bode, B. W., Aleppo, G., Hirsch, I. B., et al. (2014) · Diabetes Care · doi:10.2337/dc14-0303 · Cited by 318
Effectiveness of Continuous Glucose Monitoring in a Clinical Care Environment
Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Study Group (2010) · Diabetes Care · doi:10.2337/dc09-1502 · Cited by 313
Bergenstal, R. M., Ahmann, A. J., Bailey, T., Beck, R. W., Bissen, J., Buckingham, B., Deeb, L., Dolin, R. H., Garg, S. K., Goland, R., et al. (2013) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2013.0051 · Cited by 307
Performance Evaluation of the MiniMed® Continuous Glucose Monitoring System During Patient Home Use
Gross, T. M., Bode, B. W., Einhorn, D., Kayne, D. M., Reed, J. H., White, N. H., & Mastrototaro, J. J. (2000) · Diabetes Technology & Therapeutics · doi:10.1089/152091500316737 · Cited by 303
Assessing Sensor Accuracy for Non-Adjunct Use of Continuous Glucose Monitoring
Kovatchev, B. P., Patek, S. D., Ortiz, E. A., & Breton, M. D. (2015) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2014.0272 · Cited by 234
New and Improved Methods to Characterize Glycemic Variability Using Continuous Glucose Monitoring
Rodbard, D. (2009) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2009.0015 · Cited by 232
Self-citationContinuous glucose monitoring: an Endocrine Society Clinical Practice Guideline
Klonoff, D. C., Buckingham, B., Christiansen, J. S., Montori, V. M., Tamborlane, W. V., Vigersky, R. A., & Wolpert, H. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-2756 · Cited by 211
Kropff, J., Del Favero, S., Place, J., Toffanin, C., Visentin, R., Monaro, M., Messori, M., Di Palma, F., Lanzola, G., Farret, A., et al. (2015) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(15)00335-6 · Cited by 201
Ehrhardt, N. M., Chellappa, M., Walker, M. S., Fonda, S. J., & Vigersky, R. A. (2011) · Journal of Diabetes Science and Technology · doi:10.1177/193229681100500320 · Cited by 199
Mazze, R. S., Strock, E., Wesley, D., Borgman, S., Morgan, B., Bergenstal, R., & Cuddihy, R. (2008) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2007.0293 · Cited by 182
Garg, S. K., Schwartz, S., & Edelman, S. V. (2004) · Diabetes Care · doi:10.2337/diacare.27.3.734 · Cited by 161
Bailey, T. S., Grunberger, G., Bode, B. W., Handelsman, Y., Hirsch, I. B., Jovanovič, L., Roberts, V. L., Rodbard, D., Tamborlane, W. V., & Walsh, J. S. A. (2016) · Endocrine Practice · doi:10.4158/ep151124.cs · Cited by 149
Self-citationCGM Versus FGM; or, Continuous Glucose Monitoring Is Not Flash Glucose Monitoring
Heinemann, L., & Freckmann, G. (2015) · Journal of Diabetes Science and Technology · doi:10.1177/1932296815603528 · Cited by 147
Ambulatory Glucose Profile: Representation of Verified Self-Monitored Blood Glucose Data
Mazze, R. S., Lucido, D., Langer, O., Hartmann, K., & Rodbard, D. (1987) · Diabetes Care · doi:10.2337/diacare.10.1.111 · Cited by 144
Self-citationChase, H. P., Beck, R. W., Xing, D., Tamborlane, W. V., Coffey, J., Fox, L. A., Ives, B., Keady, J., Kollman, C., Laffel, L. M., et al. (2010) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2010.0021 · Cited by 144
Buckingham, B. A., Raghinaru, D., Cameron, F., Bequette, B. W., Chase, H. P., Maahs, D. M., Slover, R. H., Wadwa, R. P., Wilson, D. M., Ly, T. T., et al. (2015) · Diabetes Care · doi:10.2337/dc14-3053 · Cited by 140
A Comparative Effectiveness Analysis of Three Continuous Glucose Monitors
Damiano, E. R., McKeon, K., El-Khatib, F. H., Zheng, H., Nathan, D. M., & Russell, S. J. (2014) · Journal of Diabetes Science and Technology · doi:10.1177/1932296814532203 · Cited by 139
Kropff, J., Bruttomesso, D., Doll, W., Farret, A., Galasso, S., Luijf, Y. M., Mader, J. K., Place, J., Boscari, F., Pieber, T. R., et al. (2014) · Diabetes Obesity and Metabolism · doi:10.1111/dom.12378 · Cited by 136
Clinical Interpretation of Indices of Quality of Glycemic Control and Glycemic Variability
Rodbard, D. (2011) · Postgraduate Medicine · doi:10.3810/pgm.2011.07.2310 · Cited by 136
Self-citationBlevins, T. C., Bode, B. W., Garg, S. K., Grunberger, G., Hirsch, I. B., Jovanovič, L., Nardacci, E., Orzeck, E. A., Roberts, V. L., & Tamborlane, W. V. (2010) · Endocrine Practice · doi:10.4158/ep.16.5.730 · Cited by 98
Rate-of-Change Dependence of the Performance of Two CGM Systems During Induced Glucose Swings
Pleus, S., Schoemaker, M., Morgenstern, K., Schmelzeisen‐Redeker, G., Haug, C., Link, M., Zschornack, E., & Freckmann, G. (2015) · Journal of Diabetes Science and Technology · doi:10.1177/1932296815578716 · Cited by 91
A Novel Method to Detect Pressure-Induced Sensor Attenuations (PISA) in an Artificial Pancreas
Baysal, N., Cameron, F., Buckingham, B. A., Wilson, D. M., Chase, H. P., Maahs, D. M., Bequette, B. W., for the In Home Closed-Loop Study Group (IHCL), Buckingham, B. A., Wilson, D. M., et al. (2014) · Journal of Diabetes Science and Technology · doi:10.1177/1932296814553267 · Cited by 86
Matuleviciene, V., Joseph, J. I., Andelin, M., Hirsch, I. B., Attvall, S., Pivodic, A., Dahlqvist, S., Klonoff, D. C., Haraldsson, B. S., & Lind, M. (2014) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2014.0238 · Cited by 86
Accuracy and Reliability of Continuous Glucose Monitoring Systems: A Head-to-Head Comparison
Luijf, Y. M., Mader, J. K., Doll, W., Pieber, T. R., Farret, A., Place, J., Renard, É., Bruttomesso, D., Filippi, A., Avogaro, A., et al. (2013) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2013.0049 · Cited by 82
Vigersky, R. A. (2015) · Journal of Diabetes Science and Technology · doi:10.1177/1932296814565661 · Cited by 72
Forlenza, G. P., Buckingham, B. A., & Maahs, D. M. (2015) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2015.10.015 · Cited by 70
Multinight “Bedside” Closed-Loop Control for Patients with Type 1 Diabetes
Brown, S. A., Kovatchev, B. P., Breton, M. D., Anderson, S. M., Keith-Hynes, P., Patek, S. D., Jiang, B., Brahim, N. B., Vereshchetin, P., Bruttomesso, D., et al. (2015) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2014.0259 · Cited by 67
Characterizing Accuracy and Precision of Glucose Sensors and Meters
Rodbard, D. (2014) · Journal of Diabetes Science and Technology · doi:10.1177/1932296814541810 · Cited by 65
Self-citationHypoglycemia Reduction and Changes in Hemoglobin A1c in the ASPIRE In-Home Study
Weiss, R., Garg, S. K., Bode, B. W., Bailey, T. S., Ahmann, A., Schultz, K. A., Welsh, J. B., Shin, J., & for the ASPIRE In-Home Study Group (2015) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2014.0306 · Cited by 55
Garber, A. J., Abrahamson, M. J., Barzilay, J. I., Blonde, L., Bloomgarden, Z. T., Bush, M. A., Dagogo-Jack, S. E., Davidson, M., EINHORN, D. F., Garber, J. R., et al. (2015) · Endocrine Practice · doi:10.4158/ep151063.cs · Cited by 55
Augstein, P., Heinke, P., Vogt, L., Vogt, R., Rackow, C., Kohnert, K., & Salzsieder, E. (2015) · BMC Endocrine Disorders · doi:10.1186/s12902-015-0019-0 · Cited by 54
Reimbursement for Continuous Glucose Monitoring: A European View
Heinemann, L., Franc, S., Phillip, M., Battelino, T., Ampudia‐Blasco, F. J., Bolinder, J., Diem, P., Pickup, J. C., & DeVries, J. H. (2012) · Journal of Diabetes Science and Technology · doi:10.1177/193229681200600631 · Cited by 49
The Accuracy and Efficacy of the Dexcom G4 Platinum Continuous Glucose Monitoring System
Nakamura, K., & Balo, A. K. (2015) · Journal of Diabetes Science and Technology · doi:10.1177/1932296815577812 · Cited by 46
Multicenter Closed-Loop/Hybrid Meal Bolus Insulin Delivery with Type 1 Diabetes
Chase, H. P., Doyle, F. J., Zisser, H., Renard, É., Nimri, R., Cobelli, C., Buckingham, B. A., Maahs, D. M., Anderson, S. M., Magni, L., et al. (2014) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2014.0050 · Cited by 43
Roze, S., Smith‐Palmer, J., Valentine, W. J., Cook, M., Jethwa, M., de Portu, S., & Pickup, J. C. (2015) · Journal of Medical Economics · doi:10.3111/13696998.2015.1113979 · Cited by 42
Closed loop insulin delivery in diabetes
Battelino, T., Omladič, J. Š., & Phillip, M. (2015) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2015.03.001 · Cited by 42
Rodbard, D. (2014) · Journal of Diabetes Science and Technology · doi:10.1177/1932296814551046 · Cited by 41
Self-citationWalsh, J. S. A., Roberts, R., Weber, D., Faber-Heinemann, G., & Heinemann, L. (2015) · Journal of Diabetes Science and Technology · doi:10.1177/1932296815588945 · Cited by 30
Fonda, S. J., Lewis, D. G., & Vigersky, R. A. (2013) · Journal of Diabetes Science and Technology · doi:10.1177/193229681300700110 · Cited by 27
Escaping the Hemoglobin A1c-Centric World in Evaluating Diabetes Mellitus Interventions
Vigersky, R. A. (2015) · Journal of Diabetes Science and Technology · doi:10.1177/1932296815576363 · Cited by 26
Accuracy of the Sof-Sensor Glucose Sensor with the i Pro Calibration Algorithm
Welsh, J. B., KAUFMAN, F. R., & Lee, S. W. (2012) · Journal of Diabetes Science and Technology · doi:10.1177/193229681200600237 · Cited by 25
Joubert, M., Baillot-Rudoni, S., Catargi, B., Charpentier, G., Esvant, A., Franc, S., Guerci, B., Guilhem, I., Melki, V., Merlen, E., et al. (2015) · Diabetes & Metabolism · doi:10.1016/j.diabet.2015.07.001 · Cited by 22
Hypoglycemia Reduction and Accuracy of Continuous Glucose Monitoring
Kovatchev, B. P. (2015) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2015.0144 · Cited by 22
Lawson, M. L., Bradley, B., McAssey, K., Clarson, C. L., Kirsch, S. E., Mahmud, F. H., Curtis, J. R., Richardson, C., Courtney, J. M., Cooper, T., et al. (2014) · BMC Pediatrics · doi:10.1186/1471-2431-14-183 · Cited by 21
Price, D. A., Graham, C., Parkin, C. G., & Peyser, T. A. (2015) · Journal of Diabetes Science and Technology · doi:10.1177/1932296815607863 · Cited by 9
Cited by
Battelino, T., Danne, T., Bergenstal, R. M., Amiel, S. A., Beck, R., Biester, T., Bosi, E., Buckingham, B. A., Cefalu, W. T., Close, K. L., et al. (2019) · Diabetes Care · doi:10.2337/dci19-0028 · Cited by 4,237
“obstacles, clinician inexperience in data interpretation and lack of standardization software for visualization of CGM data have also played a role (73).”
Self-citationWearable biosensors for healthcare monitoring
Kim, J., Campbell, A. S., de Ávila, B. E.-F., & Wang, J. (2019) · Nature Biotechnology · doi:10.1038/s41587-019-0045-y · Cited by 3,373
Bolinder, J., Antuna, R., Geelhoed-Duijvestijn, P., Kröger, J., & Weitgasser, R. (2016) · The Lancet · doi:10.1016/s0140-6736(16)31535-5 · Cited by 893
Electrochemical glucose sensors in diabetes management: an updated review (2010–2020)
Teymourian, H., Barfidokht, A., & Wang, J. (2020) · Chemical Society Reviews · doi:10.1039/d0cs00304b · Cited by 881
Wearable non-invasive epidermal glucose sensors: A review
Kim, J., Campbell, A. S., & Wang, J. (2018) · Talanta · doi:10.1016/j.talanta.2017.08.077 · Cited by 586
Metadata
- Authors
- Rodbard, D.
- Venue
- Diabetes Technology & Therapeutics
- Publisher
- SAGE Publications
- Published
- 2016-02
- Volume
- 18
- Issue
- S2
- Pages
- S2-3-S2-13
- ISSN
- 1520-9156 (ISSN-L)
- 1557-8593
- OpenAlex
- W2278129565
- Cited by
- 737
- References
- 50
- FWCI
- 70.43
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.